Overview

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

Status:
NOT_YET_RECRUITING

Trial end date:
2031-08-15

Target enrollment:

Participant gender:

Summary

The main objective of this trial was to determine the value of concurrent chemoradiotherapy for Intermediate-risk head and neck squamous cell carcinoma

Phase:

PHASE3

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Cisplatin